Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide

Astex Pharmaceuticals Cambridge, UK
25/09/2020
Full time
Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company has successfully applied its proprietary Fragment-Based Drug Discovery platform to generate multiple new drug candidates that are progressing in clinical development. Successful collaborations have led to two launched oncology drugs (Kisqali® partnered with Novartis and BalversaTM partnered with Janssen). Astex continues to grow and focuses on Oncology and Neurological Disorders. CURIOSITY, CREATIVITY AND INNOVATIVE SCIENCE FOR DRUG DISCOVERY ...UNLOCK YOUR POTENTIAL The bioinformatics team at Astex works with multi-disciplinary project teams driving new target evaluation and preclinical and clinical research, with a focus on NGS technologies, multi-omics data, functional genomics and structural bioinformatics. We are looking for an experienced statistical bioinformatician to join the bioinformatics team with significant experience in statistical data analysis, including...
Astex Pharmaceuticals Cambridge
04/08/2020
Full time
Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company has successfully applied its proprietary Fragment-Based Drug Discovery (FBDD) platform to generate multiple new drug candidates that are progressing in clinical development. Successful collaborations have led to two launched oncology drugs (Kisqali® partnered with Novartis and BalversaTM partnered with Janssen). Astex continues to grow and focuses on Oncology and Neurological Disorders. Astex’s sustaining innovation Postdoctoral research program aims to maintain and further enhance the Company’s excellent scientific culture by fostering basic research in areas of interest to the drug discovery field, whilst working with scientists in both the biotech sector and with academic. As part of the Sustaining Innovation program, Astex now has an opening for a postdoctoral scientist to work on Artificial Intelligence (AI) methods to aid the structure-based fragment-to-lead optimisation...